Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
|
August 18, 2012
Measurement of effective piezoelectric coefficients of PZT thin films for energy harvesting application with interdigitated electrodes
Nachiappan Chidambaram, Andrea Mazzalai, Paul Muralt
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
|
July 9, 2014
Comparison of lead zirconate titanate thin films for microelectromechanical energy harvester with interdigitated and parallel plate electrodes
Nachiappan Chidambaram, Andrea Mazzalai, Davide Balma, et al.
Microsystems & Nanoengineering
|
May 7, 2019
High-aspect-ratio nanoimprint process chains
Víctor J Cadarso, Nachiappan Chidambaram, Loïc Jacot-Descombes, et al.
Hepatology Communications
|
October 7, 2020
LPCN 1144 Resolves NAFLD in Hypogonadal Males
Somaya Albhaisi, Kilyoung Kim, Jonathan Baker, et al.
Sexual Medicine Reviews
|
September 18, 2024
Newer formulations of oral testosterone undecanoate: development and liver side effects
Irwin Goldstein, Nachiappan Chidambaram, Adrian Dobs, et al.
Andrology
|
September 10, 2024
Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism
Martin Miner, Christina Wang, Jed Kaminetsky, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
June 30, 2021
Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men
William B White, Adrian Dobs, Culley Carson, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2025
Reply: Considerations on the use of LPCN 1148 in cirrhotic patients with sarcopenia
Benjamin J Bruno, Joshua C Weavil, Jonathan Ogle, et al.
Andrology
|
January 7, 2022
A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism
Anthony DelConte, Kongnara Papangkorn, Kilyoung Kim, et al.
Hepatology (Baltimore, Md.)
|
November 8, 2024
Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial
Benjamin J Bruno, Joshua C Weavil, Jonathan Ogle, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
|
August 18, 2012
Measurement of effective piezoelectric coefficients of PZT thin films for energy harvesting application with interdigitated electrodes
Nachiappan Chidambaram, Andrea Mazzalai, Paul Muralt
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control
|
July 9, 2014
Comparison of lead zirconate titanate thin films for microelectromechanical energy harvester with interdigitated and parallel plate electrodes
Nachiappan Chidambaram, Andrea Mazzalai, Davide Balma, et al.
Microsystems & Nanoengineering
|
May 7, 2019
High-aspect-ratio nanoimprint process chains
Víctor J Cadarso, Nachiappan Chidambaram, Loïc Jacot-Descombes, et al.
Hepatology Communications
|
October 7, 2020
LPCN 1144 Resolves NAFLD in Hypogonadal Males
Somaya Albhaisi, Kilyoung Kim, Jonathan Baker, et al.
Sexual Medicine Reviews
|
September 18, 2024
Newer formulations of oral testosterone undecanoate: development and liver side effects
Irwin Goldstein, Nachiappan Chidambaram, Adrian Dobs, et al.
Andrology
|
September 10, 2024
Safety, efficacy, and pharmacokinetics of oral testosterone undecanoate in males with hypogonadism
Martin Miner, Christina Wang, Jed Kaminetsky, et al.
Journal of Cardiovascular Pharmacology and Therapeutics
|
June 30, 2021
Effects of a Novel Oral Testosterone Undecanoate on Ambulatory Blood Pressure in Hypogonadal Men
William B White, Adrian Dobs, Culley Carson, et al.
Hepatology (Baltimore, Md.)
|
April 8, 2025
Reply: Considerations on the use of LPCN 1148 in cirrhotic patients with sarcopenia
Benjamin J Bruno, Joshua C Weavil, Jonathan Ogle, et al.
Andrology
|
January 7, 2022
A new oral testosterone (TLANDO) treatment regimen without dose titration requirement for male hypogonadism
Anthony DelConte, Kongnara Papangkorn, Kilyoung Kim, et al.
Hepatology (Baltimore, Md.)
|
November 8, 2024
Oral LPCN 1148 improves sarcopenia and hepatic encephalopathy in male patients with cirrhosis: A randomized, placebo-controlled phase 2 trial
Benjamin J Bruno, Joshua C Weavil, Jonathan Ogle, et al.
Page
of 1